Health
Health
Melbourne biotech signs US cancer deal for its engineered immune cells
Melbourne-based Cartherics executed a research collaboration and option agreement with the Zucker Institute, the commercialisation entity for the Medical University of South Carolina, on 1 September 2026.
Health
Melbourne medical research institute wins $10.6m for drug discovery
WEHI has received a $7 million grant from the Australian Government's Medical Research Future Fund to expand the National Drug Discovery Centre in Melbourne. WEHI is co-investing $3.6 million, taking the total program to $10.6 million.
Health
Bird flu kills a fur seal in first Australian mainland mammal death
Australia's H5 bird flu outbreak has been climbing for months, logged mostly as mortalities in seabirds and shorebirds. On 23 August 2026, the category changed.
Australia
Children with autism to lose NDIS access from 2028 under Labor deal
Health and Disability Minister Mark Butler has signalled that a parliamentary deal with the Coalition on the most significant overhaul of the National Disability Insurance Scheme since its founding is within reach.
Business
Pixel Watch 5 tracks insulin resistance without a blood test
Google is shipping a wearable feature that attempts to track insulin resistance without a needle, a lab requisition or a finger-prick device.
News
Hunter Biden says Joe Biden's cancer is 'debilitating'
Hunter Biden put his father's condition into words on BBC Newsnight this week that no White House statement would ever use. "The cancer has spread. It's metastasized into his bones and further.
News
Floods leave 723,000 Mozambicans facing acute hunger
Flooding in early 2026 affected an estimated 723,000 people across southern and central Mozambique, killed more than 146 and submerged 313,051 hectares of cropland. With about 82 per cent of the UN response plan still unfunded, the lean season is the next test.
Health
Moderna trials a first vaccine for the Ebola strain in DR Congo
The world has licensed Ebola vaccines. None of them work against the strain currently killing people in the Democratic Republic of Congo.
Health
Lilly opens expanded access to obesity drug retatrutide
Eli Lilly confirmed on 3 August 2026 it will open a formal expanded access pathway for retatrutide, its investigational triple-agonist obesity drug.